Profile
Cole Ryan is identified as the Chief Operating Officer of Aurinia Pharmaceuticals Inc. as of May 20, 2026 according to SEC filings. In this governance context, he is described as overseeing Aurinia's global operations, including manufacturing, supply chain, and general corporate operations to support the company’s lupus nephritis program and other pharmaceutical initiatives.
| Role | Chief Operating Officer |
|---|
| Notability | 45/100 |
|---|
Board memberships
- Aurinia Pharmaceuticals Inc.
Awards & honors
- Role-focused responsibilities include overseeing global operations, manufacturing, and supply chain to scale Aurinia's infrastructure.
- Positioned as part of the executive leadership referenced in the 2026 SEC filing context.
Frequently Asked Questions
Who is Cole Ryan?
Cole Ryan is identified as the Chief Operating Officer of Aurinia Pharmaceuticals Inc. as of May 20, 2026 according to SEC filings. In this governance context, he is described as overseeing Aurinia's global operations, including manufacturing, supply chain, and general corporate operations to support the company’s lupus nephritis program and other pharmaceutical initiatives.…
How many SEC Form 4 filings has Cole Ryan submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Cole Ryan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.